Elevated Serum Insulin is an Independent Risk Factor for Hepatocellular Carcinoma: A Case Control Study from Nepal
Authors:
- Satrudhan Pd GuptaSGSatrudhan Pd Gupta
- Ankush MittalAMAnkush Mittal
- Brijesh SathianBSBrijesh Sathian
- Dipendra Kumar JhaDJDipendra Kumar Jha
Open Access
- 31 December 2013
- journal article
- research article
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 14 (12) , 7331-7333
Abstract
Elevated Serum Insulin is an Independent Risk Factor for Hepatocellular Carcinoma: A Case Control Study from Nepal Insulin;glucose;serum levels;HCC risk;Nepal; Aim: To investigate associations of fasting insulin and glucose levels in serum with hepatocellular carcinoma risk. Materials and Methods: This hospital based study was carried out using data retrieved from the register maintained in the Department of Biochemistry of the Nepalese Army Institute of Health Sciences, between 1st December, 2011 and 31st June, 2013. The variables collected were age, fasting plasma glucose, fasting plasma insulin and ALT. Quantitative determination of human insulin concentrations was accomplished by chemiluminescence enzyme immunoassay. Results: Of the total 220 subjects enrolled in our present study, 20 cases were of HCC and 200 were healthy controls. The maximum number of cases of hepatocellular carcinoma in category cutpoints of fasting insulin levels fell in the range of >6.10 ${\mu}U/ml$. The highest insulin levels (>6.10 ${\mu}U/ml$) were seen to be associated with an 2.36 fold risk of HCC when compared with fasting insulin levels of (<2.75 ${\mu}U/ml$). Furthermore, the insulin levels (2.75-4.10 ${\mu}U/ml$) of category cutpoints also conferred a 1.57 fold risk for HCC when compared with lowest fasting insulin levels of (<2.75 ${\mu}U/ml$). Conclusions: The effect of an insulin level in increasing HCC risk appeared consistent, influencing incidence, risk of recurrence, overall survival, and treatment-related complications in HCC patients.
Keywords
This publication has 13 references indexed in Scilit:
- Rising Incidence of Primary Liver Cancer in Brunei DarussalamAsian Pacific Journal of Cancer Prevention, 2013
- Association of MDR1 gene polymorphisms with susceptibility to hepatocellular carcinoma in the Chinese population.Asian Pacific Journal of Cancer Prevention, 2012
- Association of Type II Diabetes Mellitus with Hepatocellular Carcinoma Occurrence - a Case Control Study from Kathmandu ValleyAsian Pacific Journal of Cancer Prevention, 2012
- The endocrine pancreas: insights into development, differentiation, and diabetesWIREs Developmental Biology, 2012
- Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: results from 17-year follow-up of a population-based cohortCarcinogenesis, 2011
- High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis CLiver International, 2007
- Glucose Modulates Basement Membrane Fibroblast Growth Factor-2 via Alterations in Endothelial Cell PermeabilityJournal of Biological Chemistry, 2007
- Therapy Insight: influence of type 2 diabetes on the development, treatment and outcomes of cancerNature Clinical Practice Oncology, 2005
- Immunologic Reactions to Insulin: Insulin Allergy, Insulin Resistance, and the Autoimmune Insulin SyndromeDiabetes Care, 1979
- Determination of Glucose in Blood Using Glucose Oxidase with an Alternative Oxygen AcceptorAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1969